XFRA IVH,PR9,U04,6L00,2KZ0,W2B,MI70,1IY0,B1Q,PI6: WIEDERAUFNAHME/RESUMPTION

Realtime	Geld	Brief	Zeit
	75,00	78,00	13:15
	75,00	78,00	13:00

Realtime

Geld

Brief

Zeit

75,00

78,00

13:15

75,00

78,00

13:00

XFRA IVH,PR9,U04,6L00,2KZ0,W2B,MI70,1IY0,B1Q,PI6: WIEDERAUFNAHME/RESUMPTION

FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.

THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:

INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
CARLTON PRECIOUS O.N. IVH CA14306B1076
LODESTAR METALS CORP. PR9 CA54020J1012
PEGASUS MERCANTILE INC. U04 CA70557Y1051
RUBELLITE ENERGY CORP. 6L00 CA7811131050
KEZAR LIFE SC.NEW DL-,001 2KZ0 US49372L2097
MAGNERA CORP. WI DL-,01 W2B US55939A1079
MIND TECHNOL. NEW DL-,01 MI70 US6025663096
MONOPAR THERAP. NEW 1IY0 US61023L2079
NRX PHARM.INC. NEW O.N. B1Q US6294442099
PALVELLA THERAPEUTICS NEW PI6 US6979471090
AB/FROM ONWARDS 17.01.2025 09:41 CET

Zeit	Aktuelle Nachrichten
17.09.	Carlton Precious Inc: Carlton to sell up to five million shares of Athena
17.09.	Carlton Precious Inc.: Carlton Precious Announces Filing of Notice of Intention to Sell Athena Gold Corporation Common Shares
10.09.	Carlton Precious Inc: Carlton Precious changes OTC symbol to CPIFF
10.09.	Carlton Precious Inc.: Carlton Announces OTC Symbol Change to CPIFF	TORONTO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Carlton Precious Inc. (TSX-V: CPI \| OTCQB: CPIFF) ("Carlton" or the "Company") is pleased to announce that effective today, the Company's common shares... ► Artikel lesen
16.07.	Carlton Precious Inc: Carlton Precious 18,303,277-share private placement

Zeit

Aktuelle Nachrichten

17.09.

Carlton Precious Inc: Carlton to sell up to five million shares of Athena

17.09.

Carlton Precious Inc.: Carlton Precious Announces Filing of Notice of Intention to Sell Athena Gold Corporation Common Shares

10.09.

Carlton Precious Inc: Carlton Precious changes OTC symbol to CPIFF

10.09.

Carlton Precious Inc.: Carlton Announces OTC Symbol Change to CPIFF

TORONTO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Carlton Precious Inc. (TSX-V: CPI | OTCQB: CPIFF) ("Carlton" or the "Company") is pleased to announce that effective today, the Company's common shares...
► Artikel lesen

16.07.

Carlton Precious Inc: Carlton Precious 18,303,277-share private placement

Zeit	Aktuelle Nachrichten
17.10.	Kezar Launches Strategic Review As FDA Roadblock Derails Liver Drug Plans
17.10.	Kezar plans layoffs after FDA cancels meeting to discuss next trial
17.10.	Kezar Life Sciences +51%: NBC-Spekulation geht auf!	Wieder ein Fall von: Mission erfolgreich! Die Aktie von Kezar Life Sciences stand im No Brainer Club die letzten Monate auf der Kaufliste. Gestern nachbörslich kam es zur Kursexplosion. Kezar Life Sciences... ► Artikel lesen
17.10.	FDA-Rückschlag: William Blair stuft Kezar Life Sciences herab
17.10.	William Blair downgrades Kezar Life Sciences stock rating on FDA setback

Zeit

Aktuelle Nachrichten

17.10.

Kezar Launches Strategic Review As FDA Roadblock Derails Liver Drug Plans

17.10.

Kezar plans layoffs after FDA cancels meeting to discuss next trial

17.10.

Kezar Life Sciences +51%: NBC-Spekulation geht auf!

Wieder ein Fall von: Mission erfolgreich! Die Aktie von Kezar Life Sciences stand im No Brainer Club die letzten Monate auf der Kaufliste. Gestern nachbörslich kam es zur Kursexplosion. Kezar Life Sciences...
► Artikel lesen

17.10.

FDA-Rückschlag: William Blair stuft Kezar Life Sciences herab

17.10.

William Blair downgrades Kezar Life Sciences stock rating on FDA setback

Zeit	Aktuelle Nachrichten
Di	Lodestar Metals Corp (2): Lodestar identifies three Au-Ag anomalies at Goldrun
Di	Lodestar Metals Corp.: Lodestar Metals Defines Three Large Gold-Silver Soil Anomalies at Goldrun Property, Nevada	Vancouver, British Columbia--(Newsfile Corp. - October 28, 2025) - Lodestar Metals Corp. (TSXV: LSTR) (OTC Pink: SVTND) ("Lodestar" or the "Company"), a junior exploration company unlocking world class... ► Artikel lesen
25.10.	Lodestar Metals Corp (2): Lodestar closes $1.12M first tranche of placement
25.10.	Lodestar Metals Corp.: Lodestar Metals Closes First Tranche of Financing	Vancouver, British Columbia--(Newsfile Corp. - October 24, 2025) - Lodestar Metals Corp. (TSXV: LSTR) (OTCQB: SVTNF) ("Lodestar" or the "Company") announces that it has closed the first tranche of... ► Artikel lesen
23.10.	Lodestar Metals Corp (2): Lodestar further increases private placement to $1.5M

Zeit

Aktuelle Nachrichten

Lodestar Metals Corp (2): Lodestar identifies three Au-Ag anomalies at Goldrun

Lodestar Metals Corp.: Lodestar Metals Defines Three Large Gold-Silver Soil Anomalies at Goldrun Property, Nevada

Vancouver, British Columbia--(Newsfile Corp. - October 28, 2025) - Lodestar Metals Corp. (TSXV: LSTR) (OTC Pink: SVTND) ("Lodestar" or the "Company"), a junior exploration company unlocking world class...
► Artikel lesen

25.10.

Lodestar Metals Corp (2): Lodestar closes $1.12M first tranche of placement

25.10.

Lodestar Metals Corp.: Lodestar Metals Closes First Tranche of Financing

Vancouver, British Columbia--(Newsfile Corp. - October 24, 2025) - Lodestar Metals Corp. (TSXV: LSTR) (OTCQB: SVTNF) ("Lodestar" or the "Company") announces that it has closed the first tranche of...
► Artikel lesen

23.10.

Lodestar Metals Corp (2): Lodestar further increases private placement to $1.5M

Zeit	Aktuelle Nachrichten
27.10.	Magnera Corporation: Magnera to Report Fourth Quarter and Fiscal Year 2025 Results on November 20th
14.10.	Should You Hold Magnera Corporation (MAGN)?
02.10.	Magnera Corp: Zwei Top-Manager kündigen Rücktritt an
02.10.	Magnera Corp - 8-K, Current Report
29.09.	Magnera to close Pilar, Argentina facility as part of restructuring

Zeit

Aktuelle Nachrichten

27.10.

Magnera Corporation: Magnera to Report Fourth Quarter and Fiscal Year 2025 Results on November 20th

14.10.

Should You Hold Magnera Corporation (MAGN)?

02.10.

Magnera Corp: Zwei Top-Manager kündigen Rücktritt an

02.10.

Magnera Corp - 8-K, Current Report

29.09.

Magnera to close Pilar, Argentina facility as part of restructuring

Zeit	Aktuelle Nachrichten
16.09.	MIND Technology Q2 FY26 presentation: 35% revenue growth amid market skepticism
10.09.	MIND TECHNOLOGY, INC - 10-Q, Quarterly Report
10.09.	Mind Technology signals stable fiscal 2026 outlook as aftermarket revenues trend higher
10.09.	Mind Technology: Starkes Wachstum im zweiten Quartal, Aktie dennoch unter Druck
09.09.	MIND TECHNOLOGY, INC - 8-K, Current Report

Zeit

Aktuelle Nachrichten

16.09.

MIND Technology Q2 FY26 presentation: 35% revenue growth amid market skepticism

10.09.

MIND TECHNOLOGY, INC - 10-Q, Quarterly Report

10.09.

Mind Technology signals stable fiscal 2026 outlook as aftermarket revenues trend higher

10.09.

Mind Technology: Starkes Wachstum im zweiten Quartal, Aktie dennoch unter Druck

09.09.

MIND TECHNOLOGY, INC - 8-K, Current Report

Zeit	Aktuelle Nachrichten
15.10.	Monopar Therapeutics Inc.: Monopar Announces Abstract Accepted for Oral Presentation at AASLD - The Liver Meeting 2025
13.10.	This Monopar Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
13.10.	Barclays initiates Monopar Therapeutics stock with Overweight rating
10.10.	Monopar stock coverage initiated at Buy by Jones Trading on Wilson's Disease drug
06.10.	Monopar stock price target raised to $142 from $80 at Raymond James

Zeit

Aktuelle Nachrichten

15.10.

Monopar Therapeutics Inc.: Monopar Announces Abstract Accepted for Oral Presentation at AASLD - The Liver Meeting 2025

13.10.

This Monopar Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

13.10.

Barclays initiates Monopar Therapeutics stock with Overweight rating

10.10.

Monopar stock coverage initiated at Buy by Jones Trading on Wilson's Disease drug

06.10.

Monopar stock price target raised to $142 from $80 at Raymond James

Zeit	Aktuelle Nachrichten
23.10.	NRX Pharmaceuticals, Inc. - 8-K, Current Report
20.10.	HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical Director
16.10.	H.C. Wainwright bestätigt Kaufempfehlung für NRx Pharmaceuticals mit Kursziel 40 USD
11.10.	New to The Street Broadcasts Tonight on Bloomberg Featuring Roadzen, Metaterra, NRx Pharma, Blackbarn NYC, and Humanitarian Travel Group	The show is sponsored programming with commercials featuring LASE Technologies ($LASE), PetVivo ($PETV), Acurx Pharmaceuticals ($ACXP), Synergy CHC ($SNYR), and NewsOut - the video press release company.... ► Artikel lesen
08.10.	NRX Pharmaceuticals stellt auf Investorenkonferenz neuartige Therapien für Depression und PTBS vor

Zeit

Aktuelle Nachrichten

23.10.

NRX Pharmaceuticals, Inc. - 8-K, Current Report

20.10.

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical Director

16.10.

H.C. Wainwright bestätigt Kaufempfehlung für NRx Pharmaceuticals mit Kursziel 40 USD

11.10.

New to The Street Broadcasts Tonight on Bloomberg Featuring Roadzen, Metaterra, NRx Pharma, Blackbarn NYC, and Humanitarian Travel Group

The show is sponsored programming with commercials featuring LASE Technologies ($LASE), PetVivo ($PETV), Acurx Pharmaceuticals ($ACXP), Synergy CHC ($SNYR), and NewsOut - the video press release company....
► Artikel lesen

08.10.

NRX Pharmaceuticals stellt auf Investorenkonferenz neuartige Therapien für Depression und PTBS vor

Zeit	Aktuelle Nachrichten
13.10.	Palvella Therapeutics Inc.: U.S. Food and Drug Administration Awards Year Two Proceeds from Orphan Products Grant Supporting Palvella Therapeutics' Phase 3 SELVA Trial of QTORIN Rapamycin for Microcystic Lymphatic Malformations	Second year proceeds granted following FDA review of annual performance progress report on Phase 3 SELVA single-arm, baseline-controlled trial; up to $2.6 million in non-dilutive funding anticipated... ► Artikel lesen
09.10.	Canaccord Genuity raises Palvella Therapeutics stock price target to $90 on new indication
02.10.	Truist hebt Kursziel für Palvella Therapeutics deutlich auf 80 US-Dollar an
02.10.	Palvella Therapeutics price target raised to $80 from $56 at Truist
26.09.	H.C. Wainwright raises Palvella Therapeutics stock price target to $95 on new indication

Zeit

Aktuelle Nachrichten

13.10.

Palvella Therapeutics Inc.: U.S. Food and Drug Administration Awards Year Two Proceeds from Orphan Products Grant Supporting Palvella Therapeutics' Phase 3 SELVA Trial of QTORIN Rapamycin for Microcystic Lymphatic Malformations

Second year proceeds granted following FDA review of annual performance progress report on Phase 3 SELVA single-arm, baseline-controlled trial; up to $2.6 million in non-dilutive funding anticipated...
► Artikel lesen

09.10.

Canaccord Genuity raises Palvella Therapeutics stock price target to $90 on new indication

02.10.

Truist hebt Kursziel für Palvella Therapeutics deutlich auf 80 US-Dollar an

02.10.

Palvella Therapeutics price target raised to $80 from $56 at Truist

26.09.

H.C. Wainwright raises Palvella Therapeutics stock price target to $95 on new indication

Zeit	Aktuelle Nachrichten
22.09.	Pegasus Mercantile Inc (2): Pegasus Mercantile to acquire Independent Retailers
13.05.	Pegasus Mercantile Inc (2): Pegasus Mercantile to settle $347,631 debt with shares
30.01.	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 30.01.2025	The following instruments on Boerse Frankfurt do have their last trading day on 30.01.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 30.01.2025ISIN NameCA7562303064 RECHARGE... ► Artikel lesen

Zeit

Aktuelle Nachrichten

22.09.

Pegasus Mercantile Inc (2): Pegasus Mercantile to acquire Independent Retailers

13.05.

Pegasus Mercantile Inc (2): Pegasus Mercantile to settle $347,631 debt with shares

30.01.

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 30.01.2025

The following instruments on Boerse Frankfurt do have their last trading day on 30.01.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 30.01.2025ISIN NameCA7562303064 RECHARGE...
► Artikel lesen

Zeit	Aktuelle Nachrichten
06.08.	Rubellite Energy GAAP EPS of $0.17, revenue of $60.54M
06.08.	Rubellite Energy Corp. Reports Record Production And Adjusted Funds Flow Per Share In Second Quarter 2025 Financial And Operating Results
16.05.	Rubellite Energy Corp: Rubellite shareholders elect eight directors at AGM
15.05.	Rubellite Energy Corp. Announces Election Of Directors
08.05.	Rubellite Energy GAAP EPS of $0.01

Zeit

Aktuelle Nachrichten

06.08.

Rubellite Energy GAAP EPS of $0.17, revenue of $60.54M

06.08.

Rubellite Energy Corp. Reports Record Production And Adjusted Funds Flow Per Share In Second Quarter 2025 Financial And Operating Results

16.05.

Rubellite Energy Corp: Rubellite shareholders elect eight directors at AGM

15.05.

Rubellite Energy Corp. Announces Election Of Directors

08.05.

Rubellite Energy GAAP EPS of $0.01

Unternehmen / Aktien	Kurs	%
CARLTON PRECIOUS INC	0,063	-5,30 %
KEZAR LIFE SCIENCES INC	5,400	+0,93 %
LODESTAR METALS CORP	0,074	+271,00 %
MAGNERA CORPORATION	7,850	+6,08 %
MIND TECHNOLOGY INC	9,850	0,00 %
MONOPAR THERAPEUTICS INC	76,00	+1,33 %
NRX PHARMACEUTICALS INC	2,720	+1,49 %
PALVELLA THERAPEUTICS INC	69,00	0,00 %
PEGASUS MERCANTILE INC	0,004	0,00 %
RUBELLITE ENERGY CORP	1,600	+7,38 %

Unternehmen / Aktien

Kurs

CARLTON PRECIOUS INC

0,063

-5,30 %

KEZAR LIFE SCIENCES INC

5,400

+0,93 %

LODESTAR METALS CORP

0,074

+271,00 %

MAGNERA CORPORATION